Shares of telehealth facilitator, drug distributor, and GLP-1 provider Hims & Hers Health Inc. (NYSE: HIMS ) have been on a rollercoaster, especially after retail investors have become much more drawn to this stock thanHi! I'm a passionate investor who has been researching publically traded companies for over 6 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term but I also dive into trend following strategies from time to time. While I have a sl ...